Biotech/Drug Stocks Q3 Earnings Due Nov 7: GILD, PRGO, VTRS & MoreZacks Investment Research • 11/06/23
Viatris (VTRS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 10/31/23
Ozempic Just Shrugged Off a Challenge From Viatris. What Does This Mean for Investors?The Motley Fool • 10/31/23
Viatris to Host Webinar: The Power of Partnership to Address Antimicrobial ResistancePRNewsWire • 10/30/23
Viatris Named to Forbes' Annual List of the World's Best Employers for the Third Year in a RowPRNewsWire • 10/23/23
Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.Business Wire • 10/10/23
Viatris Stock Bounds Higher As Divestitures Reach Nearly $7 BillionInvestors Business Daily • 10/02/23
Viatris Announces Agreements on Remaining Planned Divestitures; Upon Closing Would Achieve its Original Total Target of a Multiple Above 12x on 2022 Estimated Adjusted EBITDAPRNewsWire • 10/01/23
Viatris: Generic Semaglutide Could Become The Poor Man's Option For Weight LossSeeking Alpha • 09/29/23